Host proteins that interact with the BCG cell envelope

与 BCG 细胞包膜相互作用的宿主蛋白

基本信息

项目摘要

Project Summary The Mycobacterium bovis BCG vaccine has variable efficacy against adult pulmonary tuberculosis (TB) but protects children against both TB and unrelated infections and is used in bladder cancer treatment. Recent epidemiological studies have associated BCG vaccination with lowered COVID-19 mortality. While multiple, randomized controlled trials are now underway to test causality, molecular studies are urgently needed to address the proposed `trained [innate] immunity' mechanism of BCG cross-protection. Trained immunity may also contribute to BCG's specific protection against TB, a disease that afflicts 10 million people each year. The innate immune response to live mycobacteria or inactivated components (e.g. complete Freund's adjuvant [CFA]) has long thought to originate with the mycobacterial cell envelope, specifically the muramic acid moiety of cell wall peptidoglycan and trehalose dimycolates (TDM) in the outer `myco' membrane. During trained immunity, for example, epigenetic reprograming of monocytes depends on the innate immune receptor Nod2. Nod2, in turn, is potently stimulated by the N-glycolyl muramic acid found in mycobacteria and their relatives. Determining how fragments of the BCG envelope interact with the innate immune system may enhance our understanding of both heterologous and TB-specific protection. The molecular identities of the fragments recognized in vivo are unknown and the list of mammalian binding partners is likely incomplete. We will address these long-standing questions by synthesizing, validating and deploying clickable photoaffinity probes that either mimic envelope fragments or that incorporate into the peptidoglycan or TDM of live BCG. In proof- of-concept experiments, we will identify host proteins that interact with BCG peptidoglycan and TDM. Probes that label the envelope of live bacteria will permit host delivery of microbe-associated molecular patterns (MAMPs) in a more physiologically-relevant context. In parallel, synthesis of functionalized peptidoglycan fragments and TDM will allow head-to-head comparison of host proteins that interact with synthesized or purified MAMPs and those that interact with MAMPs released by live bacteria during infection. These experiments will reveal the earliest host–BCG interactions that may shape protection against TB and unrelated pathologies like COVID-19. Further, they will provide enabling tools to the community for studying the innate immune response to non-protein adjuvants, vaccines, and pathogens. Our approach is extendable to other glycan- and lipid-containing MAMPs (e.g., LPS).
项目概要 牛分枝杆菌 BCG 疫苗对成人肺结核 (TB) 具有不同的功效,但 保护儿童免受结核病和无关感染的侵害,并用于膀胱癌的治疗。最近的 流行病学研究表明,BCG 疫苗接种与降低 COVID-19 死亡率相关。虽然多个, 目前正在进行随机对照试验来测试因果关系,迫切需要进行分子研究 解决拟议的卡介苗交叉保护的“训练有素的[先天]免疫”机制。经过训练的免疫力可能 还有助于 BCG 对结核病(每年影响 1000 万人的疾病)提供特定保护。这 对活分枝杆菌或灭活成分(例如弗氏完全佐剂)的先天免疫反应 [CFA])长期以来一直被认为起源于分枝杆菌细胞包膜,特别是胞壁酸部分 外“真菌”膜中的细胞壁肽聚糖和海藻糖二霉菌酸酯(TDM)。训练期间 例如,单核细胞的表观遗传重编程依赖于先天免疫受体Nod2。 反过来,Nod2 会受到分枝杆菌及其近亲中发现的 N-乙醇酰胞壁酸的强烈刺激。 确定 BCG 包膜片段如何与先天免疫系统相互作用可能会增强我们的免疫能力。 了解异源保护和结核病特异性保护。片段的分子身份 体内识别的未知,并且哺乳动物结合配偶体的列表可能不完整。我们将 通过合成、验证和部署可点击的光亲和探针来解决这些长期存在的问题 要么模仿包膜片段,要么融入活卡介苗的肽聚糖或 TDM 中。证明—— 在概念实验中,我们将鉴定与 BCG 肽聚糖和 TDM 相互作用的宿主蛋白。探头 标记活细菌的包膜将允许宿主传递微生物相关的分子模式 (MAMP)在更生理相关的背景下。同时,功能化肽聚糖的合成 片段和 TDM 将允许对与合成或相互作用的宿主蛋白进行头对头比较 纯化的 MAMP 以及与感染期间活细菌释放的 MAMP 相互作用的 MAMP。这些 实验将揭示最早的宿主与卡介苗的相互作用,这可能会形成针对结核病和不相关疾病的保护作用 像 COVID-19 这样的病症。此外,他们将为社区提供研究先天性的工具。 对非蛋白质佐剂、疫苗和病原体的免疫反应。我们的方法可以扩展到其他 含有聚糖和脂质的 MAMP(例如 LPS)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Catherine Leimkuhler Grimes其他文献

PGLYRP1-mediated intracellular peptidoglycan detection promotes intestinal mucosal protection
PGLYRP1 介导的细胞内肽聚糖检测促进肠道黏膜保护
  • DOI:
    10.1038/s41467-025-57126-9
  • 发表时间:
    2025-02-21
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Shuyuan Chen;Rachel Putnik;Xi Li;Alka Diwaker;Marina Vasconcelos;Shuzhen Liu;Sudershan Gondi;Junhui Zhou;Lei Guo;Lin Xu;Sebastian Temme;Klare Bersch;Stephen Hyland;Jianyi Yin;Ezra Burstein;Brian J. Bahnson;Jeffrey C. Gildersleeve;Catherine Leimkuhler Grimes;Hans-Christian Reinecker
  • 通讯作者:
    Hans-Christian Reinecker

Catherine Leimkuhler Grimes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Catherine Leimkuhler Grimes', 18)}}的其他基金

Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
  • 批准号:
    10549646
  • 财政年份:
    2023
  • 资助金额:
    $ 21.83万
  • 项目类别:
Host proteins that interact with the BCG cell envelope
与 BCG 细胞包膜相互作用的宿主蛋白
  • 批准号:
    10288316
  • 财政年份:
    2021
  • 资助金额:
    $ 21.83万
  • 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
  • 批准号:
    10228018
  • 财政年份:
    2020
  • 资助金额:
    $ 21.83万
  • 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
  • 批准号:
    10402325
  • 财政年份:
    2020
  • 资助金额:
    $ 21.83万
  • 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
  • 批准号:
    10620744
  • 财政年份:
    2020
  • 资助金额:
    $ 21.83万
  • 项目类别:
Peptidoglycan Fragment Library to Investigate Innate Immune Responses
用于研究先天免疫反应的肽聚糖片段库
  • 批准号:
    10034684
  • 财政年份:
    2020
  • 资助金额:
    $ 21.83万
  • 项目类别:
Metabolic carbohydrate cell wall probes for bacterial structure and immune recognition studies
用于细菌结构和免疫识别研究的代谢碳水化合物细胞壁探针
  • 批准号:
    9750646
  • 财政年份:
    2017
  • 资助金额:
    $ 21.83万
  • 项目类别:
Development of an Immunostimulatory Small Molecule Library
免疫刺激小分子库的开发
  • 批准号:
    8916148
  • 财政年份:
  • 资助金额:
    $ 21.83万
  • 项目类别:
Development of an Immunostimulatory Small Molecule Library
免疫刺激小分子库的开发
  • 批准号:
    8653104
  • 财政年份:
  • 资助金额:
    $ 21.83万
  • 项目类别:
Development of an Immunostimulatory Small Molecule Library
免疫刺激小分子库的开发
  • 批准号:
    9302811
  • 财政年份:
  • 资助金额:
    $ 21.83万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 21.83万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了